Acadia Pharmaceuticals | Crediti Commerciali





Crediti Commerciali Cambiamento Data
Acadia Pharmaceuticals USD 139.44M 19.75M 2025-09
ALKERMES USD 355.11M 1.22M 2025-09
Alnylam Pharmaceuticals USD 777.57M 187.2M 2025-12
Biogen USD 1.85B 234M 2025-09
BioMarin Pharmaceutical USD 790.27M 65.59M 2025-09
Bristol-Myers Squibb USD 14.62B 485M 2025-09
Cara Therapeutics USD 2.24M 2.26M 2025-03
Corcept Therapeutics USD 69.63M 5.06M 2025-09
Cytokinetics USD 1.81M 6.6M 2025-09
Eisai JPY 249.06B 25B 2025-12
Eli Lilly USD 19.46B 2.25B 2025-09
Incyte USD 1.02B 128.52M 2025-12
J&J USD 17.61B 235M 2025-09
Moderna USD 184M 862M 2025-12
Neurocrine Biosciences USD 686.8M 41.2M 2025-12
Pfizer USD 18.12B 2.02B 2025-09
Prothena USD 5.16M 0 2023-12
PTC Therapeutics USD 203.07M 6.94M 2025-09
Sarepta Therapeutics USD 395.74M 213.86M 2025-09
Ultragenyx Pharmaceutical USD 112.54M 11.92M 2025-09
Vanda Pharmaceuticals USD 47.1M 4.35M 2024-12
Vertex Pharmaceuticals USD 2.05B 106.4M 2025-12


Acadia Pharmaceuticals Crediti Commerciali - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.